• Biomolecules & Therapeutics
• /
• 제23권6호
• /
• pp.493-509
• /
• 2015

Antibody-drug conjugates utilize the antibody as a delivery vehicle for highly potent cytotoxic molecules with specificity for tumor-associated antigens for cancer therapy. Critical parameters that govern successful antibody-drug conjugate development for clinical use include the selection of the tumor target antigen, the antibody against the target, the cytotoxic molecule, the linker bridging the cytotoxic molecule and the antibody, and the conjugation chemistry used for the attachment of the cytotoxic molecule to the antibody. Advancements in these core antibody-drug conjugate technology are reflected by recent approval of Adectris$^{(R)}$(anti-CD30-drug conjugate) and Kadcyla$^{(R)}$(anti-HER2 drug conjugate). The potential approval of an anti-CD22 conjugate and promising new clinical data for anti-CD19 and anti-CD33 conjugates are additional advancements. Enrichment of antibody-drug conjugates with newly developed potent cytotoxic molecules and linkers are also in the pipeline for various tumor targets. However, the complexity of antibody-drug conjugate components, conjugation methods, and off-target toxicities still pose challenges for the strategic design of antibody-drug conjugates to achieve their fullest therapeutic potential. This review will discuss the emergence of clinical antibody-drug conjugates, current trends in optimization strategies, and recent study results for antibody-drug conjugates that have incorporated the latest optimization strategies. Future challenges and perspectives toward making antibody-drug conjugates more amendable for broader disease indications are also discussed.

• 식품산업과 영양
• /
• 제13권2호
• /
• pp.34-40
• /
• 2008

• 한국응용약물학회:학술대회논문집
• /
• 한국응용약물학회 2007년도 Proceedings of The Convention of The Korean Society of Applied Pharmacology
• /
• pp.65-97
• /
• 2007

• 한국환경성돌연변이발암원학회:학술대회논문집
• /
• 한국환경성돌연변이발암원학회 2004년도 춘계학술대회
• /
• pp.27-29
• /
• 2004

Drug transporters play an essential role in the absorption, distribution and elimination of clinical drugs, nutrients and toxicants. The importance of the transporters is exampled by therapeutic failure in cancer chemotherapy that is mainly caused by the overexpression of multidrug resistance (MDR)-related transporters. In addition, the transporters may involve in drug-drug interactions that lead to serious adverse drug responses and some transporters also contribute to inter-individual variation in drug responses. As an effort to understand the mechanism underlying the inter-individual variation of transporters activity, genetic and environmental factors influencing the expression or function of the transporters have extensively explored through last decade. Among them, genetic polymorphism of drug transporter encoding genes has generated much interest since the discovery of functional single nucleotide polymorphisms (SNP) of MDR1 gene. Besides drug transporters, xenobiotic receptors also modulate drug disposition by regulating the transcription of drug metabolizing enzymes and drug transporters. Among many xenobiotic receptors, pregnane X receptor (PXR) and constitutive androstane receptor (CAR) are two most well characterized since these receptors show wide substrate specificities and regulate the expression of various enzymes involved in drug disposition. Recently, several functional genetic polymorphisms were reported in PXR coding gene. In the present study, genetic polymorphisms of two drug transporters, MDR1 and BCRP, and two xenobiotic receptors, PXR and CAR, were investigated in Korean population.

• 한국독성학회:학술대회논문집
• /
• 한국독성학회 2004년도 춘계학술대회
• /
• pp.27-29
• /
• 2004

Drug transporters play an essential role in the absorption, distribution and elimination of clinical drugs, nutrients and toxicants. The importance of the transporters is exampled by therapeutic failure in cancer chemotherapy that is mainly caused by the overexpression of multidrug resistance (MDR)-related transporters. In addition, the transporters may involve in drug-drug interactions that lead to serious adverse drug responses and some transporters also contribute to inter-individual variation in drug responses. As an effort to understand the mechanism underlying the inter-individual variation of transporters activity, genetic and environmental factors influencing the expression or function of the transporters have extensively explored through last decade. Among them, genetic polymorphism of drug transporter encoding genes has generated much interest since the discovery of functional single nucleotide polymorphisms (SNP) of MDRl gene. Besides drug transporters, xenobiotic receptors also modulate drug disposition by regulating the transcription of drug metabolizing enzymes and drug transporters. Among many xenobiotic receptors, pregnane X receptor (PXR) and constitutive androstane receptor (CAR) are two most well characterized since these receptors show wide substrate specificities and regulate the expression of various enzymes involved in drug disposition. Recently, several functional genetic polymorphisms were reported in PXR coding gene. In the present study, genetic polymorph isms of two drug transporters, MDR1 and BCRP, and two xenobiotic receptors, PXR and CAR, were investigated in Korean population.

• 식품과학과 산업
• /
• 제40권1호
• /
• pp.22-26
• /
• 2007

• 대한약학회:학술대회논문집
• /
• 대한약학회 2002년도 Proceedings of the Convention of the Pharmaceutical Society of Korea Vol.2
• /
• pp.366.1-366.1
• /
• 2002

Emerging medical technologies for effective and lasting repair of articular cartilage include delivery of cells or cell-seeded scaffolds to a defective site to initiate de novo tissue regeneration. In this respect. the availability of an appropriate biomaterial scaffold is crucial to allow chondrocyte growth and cartilaginous matrix deposition in a three-dimensional geometry. Hyaluronic acid (HA) molecules are anchored to the chondrocyte membrane via receptors, such as CD44. (omitted)

• Journal of Applied Biological Chemistry
• /
• 제57권3호
• /
• pp.235-242
• /
• 2014

본 연구는 국내 유통 농산물의 잔류농약 실태를 조사파악하고, 위해평가 등의 안전성 평가를 수행한 후 정부차원에서의 식품 위생/안전 정책 수립의 과학적 근거를 마련하고자 수행되었다. 시료 수거는 인구 백만 이상의 전국 9개 지역(서울, 부산, 인천, 대구, 대전, 광주, 울산, 창원 및 수원)을 선정한 후, 다소비 식품 중 대표적인 농산물 15품목(쌀, 감자, 대두, 사과, 배, 오렌지, 복숭아, 딸기, 바나나, 수박, 토마토, 오이, 애호박, 깻잎 및 무)을 선별하여 총 232건의 농산물을 수거하였다. 대상 농약은 단성분 분석으로 가능한 생장조정제 3종(dichlorprop, ethychlozate 및 6-benzylaminopurine) 및 다종다성분 분석 농약 280종, 총 283종을 선정하여 잔류농약 모니터링을 수행하였다. 분석 대상 농약들은 모니터링에 앞서 분석법을 개선하고 분석검체를 대표할 수 있는 농산물에 적용하여 국제적 기준인 CODEX 분석법 가이드라인에 준하여 분석법 검증을 수행한 후, 잔류농약 모니터링 분석법으로 사용하였다. 또한 모니터링에서 검출된 잔류농약을 대상으로 1일 섭취허용량(acceptable daily intake, ADI) 대비 1일 추정섭취량(estimated daily intake, EDI) 값으로 위해 평가를 수행하였다. 잔류농약 모니터링을 수행한 결과, 수거된 농산물 총 232건 중 163건(70.3%)에서는 농약이 검출되지 않았으며, 69건(29.7%)에서 잔류농약이 검출되었다. 검출된 농약 중 2건은 MRL을 초과하여 0.9%의 부적합률을 나타내었다. MRL을 초과한 잔류농약은 깻잎에서 검출된 chlorpyrifos와 복숭아에서 검출된 picoxystrobin이었으며, 부적합으로 나타난 chlorpyrifos 및 picoxystrobin을 포함한 검출 농약 33종에 대해 위해평가를 수행한 결과, ADI 대비 EDI는 0.00087~0.902%의 범위를 나타내었다. 이러한 결과를 통해 검출된 모든 농약은 위해도가 매우 낮은 것으로 판단됐으며, 유통되는 농산물은 잔류농약 측면에서 안전한 수준임을 확인하였다.

• 한국환경농학회지
• /
• 제32권3호
• /
• pp.207-213
• /
• 2013

Thidiazuron은 1976년 Plant Physiology 발표를 통해 생장조정제로 알려진 이후, 현재 우리나라에서도 생장조정제로 수박과 참외의 착과 증진 및 참다래의 과실비대 촉진, 포도의 과립 비대 증진 및 착립 증진 등을 위해 등록되어 사용되고 있다. Thidiazuron의 분석법은 식품공전에 수재되어 있으나, 등재 당시의 기술 이용, 일부 시험 대상 품목에 대한적용 등으로, 최근의 잔류허용기준 설정 품목의 증가와 분석기기 및 기술 발달을 반영하여 검증된 분석법으로 개선코자 하였다. 더불어, 개발된 분석법을 활용하여, thidiazuron의 사용이 허가되어 있는 수박, 키위, 포도를 포함한 국민 다소 비 식품 17품목에 대한 잔류실태조사도 수행하였다. 개발된 분석법의 회수율은, 현미 89.2~91.2 %, 고추 87.2~92.1 %, 감자 76.4~86.9 %, 수박 91.2~95.7 %, 키위 86.5~88.5 %, 포도 89.5~94.0 % 였으며, 반복 회수율 간 변이계수는 10 % 이하였다. 또한 개발된 분석법으로 우리나라에서 유통되고 있는 다소비 농산물 쌀, 상추, 사과 등 17품목 358건에 대해 농약 잔류실태를 조사한 결과 모든 시료에서 thidazulon은 검출되지 않았다.

• 분석과학
• /
• 제28권2호
• /
• pp.117-124
• /
• 2015

Genetically modified (GM) papaya line 55-1, which is resistant to PRSV infection, has been marketed globally. Prompt and sensitive protocols for specific detections are essential for the traceability of this line. Here, an event- and construct-specific real-time polymerase chain reaction (RT-PCR) method was established to detect 55-1. Qualitative detection was possible for fresh papaya fruit up to dilutions of 0.005% and 0.01% for the homozygous SunUp and heterozygous Rainbow cultivars, respectively, in non-GM papaya. The method was applied in the qualitative detection of 55-1 in eight types of commercially processed papaya products. Additionally, papaya products were monitored to distinguish GM papaya using the P35S and T-nos RT-PCR detection methods. As expected, detection capacity was improved via modified sample preparation and the established RT-PCR detection method. Taking these results together, it can be suggested that a suitable method for the extraction and purification of DNA from processed papaya products was established for the detection of GM papaya.